Reducing added sugar intake in high-risk adolescents
Administrative Supplement: Targeting added sugar to improve dietary intake in high-risk adolescents
This study is looking to help teenagers who are at risk for health issues by finding better ways to understand and improve how much sugar they eat, using new tools to track their eating habits in real-time and measure sugar intake more accurately.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11021585 on NIH RePORTER |
What this research studies
This research focuses on understanding and improving dietary habits among high-risk adolescents, particularly regarding their consumption of added sugars. By using innovative methods like ecological momentary assessment, the study aims to gather real-time data on dietary influences, which can help tailor effective behavioral interventions. Additionally, it employs a novel biomarker to objectively measure sugar intake, addressing common issues with self-reported dietary data. The goal is to develop strategies that can lead to healthier eating patterns in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 18, particularly those from low-income or minority backgrounds who are at higher risk for obesity and diet-related diseases.
Not a fit: Patients who are not adolescents or those who do not consume added sugars may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved dietary habits and reduced obesity rates among high-risk adolescents.
How similar studies have performed: Previous research has shown success in using behavioral interventions to modify dietary habits, making this approach promising yet still innovative for this specific population.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Tripicchio, Gina L. — Temple Univ of the Commonwealth
- Study coordinator: Tripicchio, Gina L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.